You are here: Home :: Area NEM :: Medical science :: Human medicine

Moshe Baru, Lea Carmel-Goren, Yechezkel Barenholz, Inbal Dayan, Savely Ostropolets, Igal Slepoy, Nira Gvirtzer, Vladimir Fukson, Jack Spira

Factor VIII efficient and specific non-covalent binding to PEGylated liposomes enables prolongation of its circulation time and haemostatic efficacy

Haemophilia A is a bleeding disorder caused by the lack of factor VIII (FVIII). We report the prolongation of exogenous FVIII circulation time and haemostatic efficacy by its formulation with PEGylated liposomes (PEGLip). FVIII binds non-covalently but with high affinity in a specific mode with the external surface of PEGLip neither losing its activity nor its binding to von Willebrand Factor. Experiments in haemophilic and non-haemophilic mice indicate that the circulation time and clotting efficacy of PEGLip-formulated exogenous FVIII (PEGLip-FVIII) are significantly enhanced over those of free FVIII. The data support the feasibility of using PEGLip-FVIII to extend the duration of haemostatic efficacy in the treatment of haemophilia A.

Thrombosis and Haemostasis, Schattauer

Print ISSN: 0340-6245
Volume: 93, 06/2005
Pages: 1061 - 1068

Show full article (external site)

Show all available items of this journal

 

Area NEM